In 2010, a three-gene panel comprised GDF15, TMEFF2 and VIM methylation identified BlCa with 94% sensitivity and 100% specificity in urine samples from 51 BlCa patients [11]. This evidence concerns the gene TMEFF2 and bladder transitional cell carcinoma.